APA (7th ed.) Citation

Y, L., JN, C., J, C., Z, T., M, P., & S, Z. (2019). Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Li, Connarn JN, Chen J, Tong Z, Palmisano M, and Zhou S. Modeling and Simulation of the Endogenous CYP3A Induction Marker 4β-hydroxycholesterol During Enasidenib Treatment. Dove Medical Press, 2019.

MLA (8th ed.) Citation

Y, Li, et al. Modeling and Simulation of the Endogenous CYP3A Induction Marker 4β-hydroxycholesterol During Enasidenib Treatment. Dove Medical Press, 2019.